Scope of practice changes in community pharmacy
GBMA is aware of community pharmacy’s increased scope of practice and the ongoing trials in each state. We understand that the increased scope of practice for pharmacy and pharmacists in Australia is limited to a controlled cohort of disease states, with appropriate governance, training and protocols put in place by State and Territory Governments to mitigate any potential conflicts of interest.
The generic and biosimilar medicines association uses its Code of Practice to encourage member compliance with relevant legislation in environments that we operate. GBMA has demonstrated its compliance with industry standards for more than 10 years without any complaints raised.